{"id":1873,"date":"2025-09-02T13:56:20","date_gmt":"2025-09-02T18:56:20","guid":{"rendered":"https:\/\/www.rqmplus.com\/?post_type=team&#038;p=1873"},"modified":"2025-09-02T13:56:20","modified_gmt":"2025-09-02T18:56:20","slug":"frank-maier","status":"publish","type":"team","link":"https:\/\/www.rqmplus.com\/about\/team\/frank-maier\/","title":{"rendered":"Frank Maier"},"content":{"rendered":"\n<p>Frank Maier serves as Vice President, EU Operations at RQM+ with over 15 years of experience in the medical device and IVD industry. While demonstrating profound knowledge of regulatory requirements like ISO 14155, ISO 20916, (EU) MDR 2017\/745 and (EU) IVDR 2017\/746, he provides corporate-wide strategic, operational, and functional leadership of RQM+ for Europe and the associated business operations. Frank\u00b4s in-depth knowledge includes a wide range of therapeutic areas in both pre- and postmarket clinical investigations in the EU and APAC region.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Frank Maier serves as Vice President, EU Operations at RQM+ with over 15 years of experience in the medical device&#8230;<\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":true,"_links_to":"","_links_to_target":""},"team-type":[38],"team-topics":[],"class_list":["post-1873","team","type-team","status-publish","hentry","team-type-global-operations-medical-affairs"],"acf":[],"card_info":{"title":"Frank Maier","link":"https:\/\/www.rqmplus.com\/about\/team\/frank-maier\/","link_target":"_self","name":"Leader","slug":"team","thumbnail":false,"excerpt":"Frank Maier serves as Vice President, EU Operations at RQM+ with over 15 years of experience in the medical device...","display_date":"September 2, 2025"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Frank Maier | RQM+<\/title>\n<meta name=\"description\" content=\"Frank Maier serves as Vice President, EU Operations at RQM+ with over 15 years of experience in the medical device and IVD industry. While demonstrating profound knowledge of regulatory requirements like ISO 14155, ISO 20916, (EU) MDR 2017\/745 and (EU) IVDR 2017\/746, he provides corporate-wide strategic, operational, and functional leadership of RQM+ for Europe and the associated business operations. Frank\u00b4s in-depth knowledge includes a wide range of therapeutic areas in both pre- and postmarket clinical investigations in the EU and APAC region.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rqmplus.com\/about\/team\/frank-maier\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Frank Maier | RQM+\" \/>\n<meta property=\"og:description\" content=\"Frank Maier serves as Vice President, EU Operations at RQM+ with over 15 years of experience in the medical device and IVD industry. While demonstrating profound knowledge of regulatory requirements like ISO 14155, ISO 20916, (EU) MDR 2017\/745 and (EU) IVDR 2017\/746, he provides corporate-wide strategic, operational, and functional leadership of RQM+ for Europe and the associated business operations. Frank\u00b4s in-depth knowledge includes a wide range of therapeutic areas in both pre- and postmarket clinical investigations in the EU and APAC region.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rqmplus.com\/about\/team\/frank-maier\/\" \/>\n<meta property=\"og:site_name\" content=\"RQM+\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RQMplus\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/02\/rqm-og.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@RQMplus\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.rqmplus.com\/about\/team\/frank-maier\/\",\"url\":\"https:\/\/www.rqmplus.com\/about\/team\/frank-maier\/\",\"name\":\"Frank Maier | RQM+\",\"isPartOf\":{\"@id\":\"https:\/\/www.rqmplus.com\/#website\"},\"datePublished\":\"2025-09-02T18:56:20+00:00\",\"description\":\"Frank Maier serves as Vice President, EU Operations at RQM+ with over 15 years of experience in the medical device and IVD industry. While demonstrating profound knowledge of regulatory requirements like ISO 14155, ISO 20916, (EU) MDR 2017\/745 and (EU) IVDR 2017\/746, he provides corporate-wide strategic, operational, and functional leadership of RQM+ for Europe and the associated business operations. Frank\u00b4s in-depth knowledge includes a wide range of therapeutic areas in both pre- and postmarket clinical investigations in the EU and APAC region.\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.rqmplus.com\/about\/team\/frank-maier\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.rqmplus.com\/#website\",\"url\":\"https:\/\/www.rqmplus.com\/\",\"name\":\"RQM+\",\"description\":\"Evolving MedTech\",\"publisher\":{\"@id\":\"https:\/\/www.rqmplus.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.rqmplus.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.rqmplus.com\/#organization\",\"name\":\"RQM+\",\"url\":\"https:\/\/www.rqmplus.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.rqmplus.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/02\/logo.png\",\"contentUrl\":\"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/02\/logo.png\",\"width\":696,\"height\":696,\"caption\":\"RQM+\"},\"image\":{\"@id\":\"https:\/\/www.rqmplus.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/RQMplus\",\"https:\/\/x.com\/RQMplus\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Frank Maier | RQM+","description":"Frank Maier serves as Vice President, EU Operations at RQM+ with over 15 years of experience in the medical device and IVD industry. While demonstrating profound knowledge of regulatory requirements like ISO 14155, ISO 20916, (EU) MDR 2017\/745 and (EU) IVDR 2017\/746, he provides corporate-wide strategic, operational, and functional leadership of RQM+ for Europe and the associated business operations. Frank\u00b4s in-depth knowledge includes a wide range of therapeutic areas in both pre- and postmarket clinical investigations in the EU and APAC region.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rqmplus.com\/about\/team\/frank-maier\/","og_locale":"en_US","og_type":"article","og_title":"Frank Maier | RQM+","og_description":"Frank Maier serves as Vice President, EU Operations at RQM+ with over 15 years of experience in the medical device and IVD industry. While demonstrating profound knowledge of regulatory requirements like ISO 14155, ISO 20916, (EU) MDR 2017\/745 and (EU) IVDR 2017\/746, he provides corporate-wide strategic, operational, and functional leadership of RQM+ for Europe and the associated business operations. Frank\u00b4s in-depth knowledge includes a wide range of therapeutic areas in both pre- and postmarket clinical investigations in the EU and APAC region.","og_url":"https:\/\/www.rqmplus.com\/about\/team\/frank-maier\/","og_site_name":"RQM+","article_publisher":"https:\/\/www.facebook.com\/RQMplus","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/02\/rqm-og.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@RQMplus","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.rqmplus.com\/about\/team\/frank-maier\/","url":"https:\/\/www.rqmplus.com\/about\/team\/frank-maier\/","name":"Frank Maier | RQM+","isPartOf":{"@id":"https:\/\/www.rqmplus.com\/#website"},"datePublished":"2025-09-02T18:56:20+00:00","description":"Frank Maier serves as Vice President, EU Operations at RQM+ with over 15 years of experience in the medical device and IVD industry. While demonstrating profound knowledge of regulatory requirements like ISO 14155, ISO 20916, (EU) MDR 2017\/745 and (EU) IVDR 2017\/746, he provides corporate-wide strategic, operational, and functional leadership of RQM+ for Europe and the associated business operations. Frank\u00b4s in-depth knowledge includes a wide range of therapeutic areas in both pre- and postmarket clinical investigations in the EU and APAC region.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rqmplus.com\/about\/team\/frank-maier\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.rqmplus.com\/#website","url":"https:\/\/www.rqmplus.com\/","name":"RQM+","description":"Evolving MedTech","publisher":{"@id":"https:\/\/www.rqmplus.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rqmplus.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.rqmplus.com\/#organization","name":"RQM+","url":"https:\/\/www.rqmplus.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rqmplus.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/02\/logo.png","contentUrl":"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/02\/logo.png","width":696,"height":696,"caption":"RQM+"},"image":{"@id":"https:\/\/www.rqmplus.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RQMplus","https:\/\/x.com\/RQMplus"]}]}},"_links":{"self":[{"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/team\/1873","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/team"}],"about":[{"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/types\/team"}],"version-history":[{"count":0,"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/team\/1873\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/media?parent=1873"}],"wp:term":[{"taxonomy":"team-type","embeddable":true,"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/team-type?post=1873"},{"taxonomy":"team-topics","embeddable":true,"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/team-topics?post=1873"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}